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Background: Aortic valve replacement in patients with severe atherosclero-
sis of the ascending aorta poses technical challenges. The purpose of this
study was to examine operative strategies and results of aortic valve replace-
ment in patients with a severely atherosclerotic ascending aorta that could
not be safely crossclamped.
Patients and methods: From January 1990 to December 1998, 4983 patients
had aortic valve surgery; of these, 62 (1.2%) patients had a severely athero-
sclerotic ascending aorta and required hypothermic circulatory arrest to
facilitate aortic valve replacement. They form the study group.
Results: All patients had hypothermic circulatory arrest, but several different
strategies were used to manage the ascending aorta. These techniques includ-
ed aortic valve replacement with the use of hypothermic circulatory arrest
(39%), ascending aortic endarterectomy (26%), ascending aortic replace-
ment (19%), aortic inspection and crossclamping during hypothermic circu-
latory arrest (10%), and balloon occlusion of the ascending aorta (6%).
Duration of hypothermic circulatory arrest was substantially longer for
patients having aortic valve replacement with hypothermic circulatory arrest
than for all other strategies. Hospital mortality was 14%, and 10% of patients
had strokes. Increasing New York Heart Association functional class and
impaired left ventricular function were risk factors for hospital mortality.
Choice of operative technique did not influence patient outcome; however,
no patient who underwent replacement of the ascending aorta had a stroke.
Conclusions: Aortic valve replacement in patients with severe atherosclerosis
of the ascending aorta is associated with increased operative morbidity and
mortality. Complete aortic valve replacement during hypothermic circulato-
ry arrest, the “no-touch” technique, requires a prolonged period of circulato-
ry arrest. Ascending aortic replacement is a preferred technique, as it
requires a short period of hypothermic circulatory arrest and results in com-
parable mortality with a low risk of stroke. (J Thorac Cardiovasc Surg
2000;120:957-65)
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A ortic atherosclerosis and calcification complicatecardiac surgery. In patients with severe atheroscle-
rosis of the ascending aorta, coronary artery bypass
grafting (CABG) can be done without cardiopulmonary
bypass (CPB) and mitral and tricuspid valve surgery
can be performed without aortic clamping. Un-
fortunately, no such options are available for patients
who require aortic valve surgery. Therefore, aortic
valve surgery in the patient with severe atherosclerosis
of the ascending aorta requires modifications of tech-
niques for CPB and cardiac arrest. The optimal
approach for aortic valve surgery in such patients is
unknown. The purpose of this study was to examine
operative strategies and results of aortic valve replace-
ment (AVR) in patients with a severely atherosclerotic
ascending aorta that could not be safely crossclamped.
Patients and methods
Patients. From January 1990 to December 1998, 4983
patients had aortic valve surgery at The Cleveland Clinic
Foundation. Operative reports were reviewed to identify those
patients in whom hypothermic circulatory arrest (HCA) was
used to manage a severely atherosclerotic ascending aorta at
AVR. Sixty-two such patients (1.2%) were identified, and they
form the study group. Patients with ascending aortic dissection
or aortic aneurysm were excluded. Similarly, patients (not
specifically identified) who had ascending aortic atherosclero-
sis and who did not have HCA were not part of the study.
Mean age was 72 ± 8 years (range 37-87 years); 55% were
male. Forty-five percent had pure aortic stenosis, and 55% had
mixed aortic stenosis and aortic regurgitation. Eighty-two per-
cent of patients had coronary artery disease, and 43% had other
valvular heart lesions. Left ventricular function was normal in
45%, mildly depressed in 16%, moderately depressed in 14%,
moderately to severely depressed in 13%, and severely
depressed in 10%; in 1 patient, left ventricular function could
not be determined. Twenty-five (40%) patients had previous
cardiac surgery, including CABG in 18. Three patients had 2
previous cardiac operations, and 3 patients had median ster-
notomy and an aborted procedure when aortic calcification was
recognized. Eight patients had a history of mediastinal irradia-
tion. Comorbid conditions are listed in Table I.
Aortic atherosclerosis was suspected preoperatively in only
50% of patients. All patients had preoperative chest radio-
graphs, cardiac catheterization, and transthoracic echocardio-
grams. Additional preoperative studies included trans-
esophageal echocardiography (5 patients), chest computed
tomographic scan (7 patients), and thoracic magnetic reso-
nance imaging (2 patients).
Definitions. Stroke was defined as a permanent neurologic
deficit not present preoperatively and persisting at the time of
hospital discharge. Perioperative myocardial infarction was
defined as the appearance of new Q waves on the electrocar-
diogram or elevation of cardiac enzymes. Postoperative ven-
tilatory insufficiency was defined as the need for mechanical
ventilation for more than 48 hours after the operation.
Data analysis. The Fisher exact test and univariate logistic
regression analyses were performed to detect predictors of
operative mortality or stroke because the number of events was
too small for multivariable analyses to be performed. The
Kruskal-Wallis test was used to compare the operative tech-
niques with respect to durations of HCA and CPB. All statisti-
cal testing was conducted with the use of 2-sided alternatives
with a type I error level of .05. Unless otherwise specified, all
values are expressed as mean ± standard deviation.
Results
Intraoperative evaluation of the aorta included palpa-
tion (100%), transesophageal echocardiography (79%),
and epiaortic echocardiography (13%). In each case the
surgeon judged that the aorta could not be safely cross-
clamped. The pathology of the ascending aorta was
classified as an “eggshell” or “porcelain” aorta in 18%,
diffuse calcification in 66%, and noncalcified athero-
mata in 14%.
Although the ascending aorta or aortic arch was can-
nulated in 34%, the majority of patients had alternate
sites of arterial cannulation; these included the femoral
artery (34%), the axillary artery (24%), and the innom-
inate artery (8%). All patients had AVR, and the aortic
prostheses implanted included the following:
Carpentier-Edwards bioprostheses (79%, Baxter
Healthcare Corp, Newport Beach, Calif), St Jude
Medical mechanical prostheses (18%, St Jude Medical,
Inc, St Paul, Minn), and allograft aortic root (3%,
CryoLife, Inc, Kennesaw, Ga). Fifty-eight percent of
patients had concomitant procedures (Table II). A peri-
od of HCA was used in each case to facilitate AVR.
Five different strategies were used in conjunction with
HCA (Table III). The most common approach included
excision of the native aortic valve and prosthetic valve
replacement during a prolonged period of HCA (24
patients, 39%). Strategies that included definitive treat-
ment of ascending aortic atherosclerosis were aortic
endarterectomy (16 patients) and ascending aortic
replacement (12 patients) (Fig 1). In 6 patients, inspec-
tion of the aorta during HCA revealed a safe spot for
aortic clamping. In 4 patients, a Foley catheter was
introduced through the aortotomy during a brief period
of HCA; the balloon was then inflated, CPB resumed,
and AVR performed during rewarming.
Mean duration of HCA for the entire group was 28 ±
24 minutes, with a range of 1 to 100 minutes. The dura-
tion of HCA was greatest in patients having AVR with
HCA (Table III). Mean duration of CPB was 159 ± 64
minutes; the differences in CPB times among groups
were no greater than expected by chance (P = .64).
Mean nasopharyngeal and core temperatures at the ini-
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tiation of HCA were 18°C ± 3°C and 21°C ± 4°C,
respectively; the differences among groups were no
greater than expected by chance (P = .69). Retrograde
cerebral perfusion during HCA was used in 38 patients
(61%). Cardioplegia techniques included retrograde
cardioplegia (76%), retrograde and antegrade cardio-
plegia (13%), antegrade cardioplegia (3%), and no car-
dioplegia (8%).
Nine postoperative deaths occurred, a hospital mor-
tality of 14%. This compares with a hospital mortality
of 0.5% for isolated AVR in our institution. Causes of
death included myocardial infarction (5 patients),
pneumonia (2 patients), prosthetic valve endocarditis
(1 patient), and atheroembolic shower (1 patient).
Increasing New York Heart Association functional
class (P = .02), impaired left ventricular function (P =
.02), and history of abdominal aortic aneurysm (P =
.05) were risk factors for hospital mortality. Choice of
operative technique did not influence hospital mortali-
ty (P = .70). There was a trend toward increased hospi-
tal mortality in patients with a porcelain or eggshell
aorta (P = .08).
Hospital morbidity is detailed in Table IV. Six (10%)
patients had perioperative strokes, and 3 died. These
included embolic strokes identified by computed tomo-
graphic scan in 5 patients and a diffuse anoxic insult in
1 patient. Risk factors for stroke included abdominal
aortic aneurysm (P = .02) and porcelain aorta (P = .07).
Although 4 of the 6 strokes occurred in patients having
femoral arterial cannulation, the site of arterial access
did not emerge as a risk factor for stroke (P = .4) or
death (P = .9). Although strokes were limited to
patients having AVR with HCA and aortic endarterec-
tomy, statistical analysis revealed that the risk of stroke
was independent of procedure-related variables. Nine
(14%) patients had transient confusion that cleared by
the time of hospital discharge. The most common com-
plication was postoperative ventilatory insufficiency,
which occurred in 19 patients (31%); 2 of these
patients required tracheostomy.
As noted previously, 11 patients (18%) had a circum-
ferentially calcified eggshell or porcelain aorta.
Management strategies varied in these patients and
included AVR with HCA (4 patients), aortic end-
arterectomy (2 patients), ascending aortic tube graft (3
patients), balloon occlusion (1 patient), and inspection
followed by crossclamp application distal to the calci-
um (1 patient). In general, a localized endarterectomy
was necessary to facilitate the aortic suture line.
Patients with a porcelain aorta had a particularly high
morbidity and mortality, with 3 of 11 dying in the hos-
pital and 3 having strokes.
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Table I.  Comorbid conditions in 62 patients with
ascending aortic atherosclerosis 
Condition* No. %
Peripheral vascular disease 35 56
Carotid stenosis 22 35
Previous stroke 7 11
Hypertension 29 47
Chronic obstructive pulmonary disease 18 29
Diabetes mellitus 14 22
Chronic renal insufficiency 9 14
Mediastinal radiation therapy 8 13
*Conditions are not mutually exclusive.
Table II.  Concomitant procedures in patients having
AVR
Procedure No.
CABG 27
CABG and carotid endarterectomy 3
CABG and MVR 1
CABG and aortic root enlargement 3
Myectomy and aortic root enlargement 1
Mitral valve debridement 1
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting; MVR,
mitral valve replacement.
Table III.  Management of the ascending aorta during HCA
AVR during Aortic Ascending Inspect and Balloon
Variable HCA endarterectomy aortic tube graft crossclamp occlusion
No. 24 16 12 6 4
HCA (min) 54 ± 18* 13 ± 6 17 ± 6 4 ± 5 5 ± 4
Stroke† 4 (17%; 9%-28%) 2 (12%; 4%-27%) 0 (0%; 0%-15%) 0 (0%; 0%-27%) 0 (0%; 0%-38%)
Mortality† 3 (12%; 6%-24%) 3 (19%; 8%-34%) 3 (25%; 11%-44%) 0 (0%; 0%-27%) 0 (0%; 0%-38%)
HCA, Hypothermic circulatory arrest; AVR, aortic valve replacement.
*P < .001 versus other techniques.
†Presented as number, percent, and 70% confidence limits.
Comment
Atherosclerosis of the ascending aorta and aortic arch
is an important cause of embolic disease, and the pres-
ence of atherosclerotic plaques in the ascending aorta and
proximal arch is a risk factor for ischemic stroke.1-4 In a
landmark study, Blauth and coworkers1 demonstrated the
importance of atheroembolism from the ascending aorta
in patients having cardiac operations. Their review of
autopsy findings in 221 patients having cardiac surgery
revealed that 22% had atheroemboli, with the brain being
the most commonly affected site. Of particular interest,
atheroembolic events occurred in 37% of patients with
severe disease of the ascending aorta but in only 2% of
patients without important ascending aortic disease.
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Fig 1. Technique for replacement of the ascending aorta with HCA. A, CPB is established via a cannula placed in
a 6- or 8-mm Dacron graft sewn to the axillary artery and cannulas in the superior and inferior venae cavae. A ret-
rograde cardioplegia catheter is placed through the right atrium. B, Distal coronary anastomoses are completed dur-
ing systemic cooling. When the systemic temperature is 18°C, the circulation is arrested. Retrograde cerebral per-
fusion via the superior vena cava is at 200 to 400 mL/min. The diseased aorta is excised. C, The distal anastomosis
is completed during HCA. Systemic perfusion is then reinstituted and the graft is clamped. D, The proximal aortic
anastomosis and proximal coronary anastomosis are completed during rewarming.
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While Blauth and coworkers1 have identified the
importance of ascending aortic atherosclerosis in the
patient having cardiac surgery, appropriate manage-
ment of this condition is predicated on the surgeon’s
recognition of the aortic disease. Preoperative patient
profiles are of limited utility in predicting the likeli-
hood of ascending aortic atherosclerosis. Increased
patient age is the most consistent risk factor for the
condition.1,5-7 One third of patients older than 80 years
who undergo cardiac surgery have important ascending
aortic atherosclerosis.5 Other documented risk factors
include carotid artery disease, abdominal aortic
aneurysm, left main coronary artery disease, diabetes,
hypertension, and history of cerebral emboli of
unknown source.1,6-10 Unfortunately, the majority of
patients undergoing cardiac surgery have one or more
of these conditions. On occasion, ascending aortic cal-
cification may be recognized on the chest x-ray film or
during cardiac catheterization10; however, these studies
identify moderate to severe ascending aortic athero-
sclerosis in only one quarter of affected patients.7,9
Gentle palpation of the ascending aorta is useful to
detect extensive calcification. However, in a study of
500 patients, Wareing and associates9 found palpation
an insensitive technique, identifying significant athero-
matous disease in only 38% of affected patients and
underestimating its severity routinely. Although King
and associates11 demonstrated that chest computed
tomographic scans were very accurate in predicting
severe atheromatous disease and the need for HCA, it
is impractical to obtain such scans in all patients at risk.
Echocardiography has emerged as a useful technolo-
gy for detection of ascending aortic atherosclerosis.
Transesophageal echocardiography is more sensitive
than palpation for the detection of atheromatous dis-
ease of the ascending aorta.12 Protruding atheromata
detected by transesophageal echocardiography are a
risk factor for stroke in elderly patients undergoing
CPB.12 However, even with multiplane trans-
esophageal echocardiography, it is difficult to detect
disease in the distal ascending aorta, the usual site for
cannulation and aortic clamping.6,9 Epiaortic echocar-
diography does not have this limitation, and this
modality is the most sensitive technique for detecting
ascending aortic atherosclerosis. In a study of 100 con-
secutive patients having cardiac surgery, Sylivris and
colleagues6 detected ascending aortic disease in 16%
by palpation and in 90% by epiaortic ultrasonography.
These authors also found that epiaortic ultrasonogra-
phy was more sensitive than transesophageal echocar-
diography for examining the mid and distal ascending
aorta. Davila-Roman,7 Wareing,8,9 and their associates
from Washington University have the greatest experi-
ence with epiaortic ultrasonography and they report
similar results. They recommend intraoperative ultra-
sound scanning in all patients 70 years of age or older
undergoing cardiac operations. Ohteki and coworkers13
have demonstrated that epiaortic ultrasound is more
sensitive than preoperative computed tomographic
scanning. Although infrequently used in the current
series, epiaortic ultrasound is the technique of choice
for detection of ascending aortic atherosclerosis.
When a severely atherosclerotic ascending aorta is
recognized before institution of CPB, alteration of per-
fusion and crossclamping techniques decreases the risk
of stroke. Wareing and associates8 reported a 6%
occurrence of stroke in patients with moderate to
severe atherosclerosis of the ascending aorta who had
minor modifications in operative technique; in contrast,
similar patients who had ascending aortic replacement
had no strokes. Patients who have ascending aortic ath-
erosclerosis and require isolated CABG can be treated
by a variety of techniques. Mills and Everson10 have
described CABG with CPB and without aortic clamp-
ing. They used the left internal thoracic artery for
inflow with multiple T and Y grafts. Other approaches
that use CPB include construction of proximal anasto-
moses during a brief period of HCA,14 aortic
endarterectomy,15 and replacement of the ascending
aorta with a tube graft.16 All of these techniques entail
aortic manipulation. In contrast, off-pump CABG with
the internal thoracic arteries used for inflow avoids all
aortic manipulation; therefore, this technique may be
preferred when feasible.
Unlike coronary artery surgery, aortic valve proce-
dures require both CPB and aortic manipulation. AVR
in patients with severe atherosclerosis of the ascending
aorta requires either aortic clamping or a period of
HCA. Several reports describe techniques for manag-
ing aortic valve disease in limited numbers of these
patients. Coselli and Crawford17 and Byrne, Aranki,
and Cohn18 have described a “no-touch” technique for
such patients. An alternate site for arterial cannulation
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Table IV.  Postoperative morbidity
Morbidity No. % CL
Stroke 6 10 6-15
Confusion 9 15 10-21
Ventilatory insufficiency 19 31 24-38
MI 5 8 5-13
Wound infection 5 8 5-13
Reoperation for bleeding 4 6 3-11
Renal failure 2 3 1-7
Ventricular tachycardia 1 2 0.2-5
CL, 70% confidence limits; MI, perioperative myocardial infarction.
is chosen, the patient is cooled, and AVR is performed
during a period of HCA. Although this approach was
successful in these 2 reports of small numbers of
patients, the duration of HCA ranged from 38 to 65
minutes. Opting for a different strategy, Svensson and
coworkers19 reported successful aortic endarterectomy
to facilitate AVR in 6 patients with a calcified ascend-
ing aorta. They and others have not observed aortic
dilatation after aortic endarterectomy, but long-term
follow-up is unavailable.19,20 Wareing and colleagues8
have reported excellent results with replacement of the
ascending aorta in patients with aortic atherosclerosis
who require AVR. Others, however, consider this too
extensive a procedure18 and have been unable to dupli-
cate their results.11 Cosgrove21 reported balloon occlu-
sion of the ascending aorta after performing an aortoto-
my with the aid of HCA; this requires a very brief
period of HCA, but there may still be the risk of dis-
lodging emboli.18
The preceding reports describe small numbers of
patients having AVR in the setting of an atherosclerot-
ic calcified aorta, and no larger series comparing dif-
ferent surgical strategies have been reported. The pur-
pose of this study was to examine operative strategies
and results in a large series of patients with ascending
aortic atherosclerosis who required AVR. In this group
of patients with aortic valve disease and severe ascend-
ing aortic atherosclerosis, operative morbidity and mor-
tality were high. This may be attributed in part to the
high proportion of reoperations and comorbid condi-
tions, such as radiation heart disease. However, it is
likely that ascending aortic and diffuse atherosclerosis
coupled with the magnitude of the surgical procedures
were the major causes for increased operative risk.
Although all patients had HCA, 5 different strategies
were used to manage the ascending aorta. The most
commonly used strategy was AVR during HCA with a
“no-touch” technique as described by Coselli and
Crawford17 and Byrne, Aranki, and Cohn.18 This
approach required an HCA period far longer than for
the other techniques. There was some success with aor-
tic endarterectomy; however, this procedure may be
associated with dislodgment of atherosclerotic debris,
and the long-term fate of the thinned aorta is
unknown.20 In a few patients, inspection of the aorta
during HCA revealed a safe spot for aortic clamping;
this is a favorable situation, but it was uncommon in
our experience. Balloon occlusion was also a success-
ful strategy for the few patients in whom it was used. 
Like Kouchoukos and associates,16 we presently
favor ascending aortic replacement with a tube graft in
patients who require AVR and have a severely and dif-
fusely atherosclerotic ascending aorta. Advantages of
this technique include absence of aortic manipulation
before HCA, resection of the diseased segment of
aorta, and a relatively brief period of HCA. Although
the differences in mortality and stroke between patients
based on surgical technique could be due to chance, no
patient with ascending aortic replacement had a stroke.
Recent adjuncts, including axillary artery cannulation
and retrograde cerebral perfusion, may further improve
the results of this technique. In a series of 47 patients
with coronary disease who had ascending aortic
replacement, Kouchoukos and associates16 reported a
4% mortality and no strokes. We believe that future
study of larger numbers of patients having AVR with
this technique is likely to demonstrate advantages to
this approach.
Limitations
This is an observational clinical study examining
patients in whom HCA was used to facilitate AVR in
the setting of a severely atherosclerotic ascending
aorta. Operative techniques were chosen by the sur-
geon in a nonrandomized fashion. Patients with severe
ascending aortic atherosclerosis who did not have HCA
were not identified; therefore, we cannot compare mor-
bidity and mortality in such patients with those in
patients who did have HCA. Although epiaortic
echocardiography is now used routinely in the evalua-
tion of patients with ascending aortic atherosclerosis,
in the current series such patients were in the minority.
The majority of patients had aortic calcification that
was detectable by palpation, and it is likely that the
severity and extent of ascending aortic atherosclerosis
were underestimated. Patients with ascending aortic
atherosclerosis who did not have HCA were not includ-
ed in this report; thus, the impact of HCA in these
patients cannot be analyzed. Finally, the relatively
small number of patients in this report precluded mul-
tivariable analysis with adjustments for possible differ-
ences among the patients in various subgroups. Our
ability to determine the superiority of one surgical
technique over another was thereby limited.
Conclusion
AVR in patients with severe atherosclerosis of the
ascending aorta is associated with increased operative
morbidity and mortality. Complete AVR with HCA, the
“no-touch” technique, requires a prolonged period of
HCA and does not prevent strokes. Ascending aortic
replacement is a preferred technique, as it requires a
short period of HCA and results in comparable mortal-
ity with a low risk of stroke.
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Discussion
Dr Nicholas T. Kouchoukos (St Louis, Mo). In a retro-
spective analysis, Dr Lytle and his colleagues have identified
62 patients undergoing AVR in whom HCA was used for
management of a severely atherosclerotic ascending aorta.
The patients were elderly, had a high prevalence of coronary
artery disease, and had a substantial prevalence of other
valvular lesions, abnormal ventricular function, and previous
cardiac operations. Although porcelain or calcified aortas
were discussed, noncalcified atheromatous lesions were pre-
sent in 14% of these patients. In our experience, these “soft”
lesions are the most dangerous and can only be identified
accurately by epiaortic scanning. 
The technique that Lytle and his colleagues used most fre-
quently for management of these problems was AVR during
a period of HCA. This was associated with the highest inci-
dence of stroke, 17%, although the differences between this
stroke rate and those observed with the other techniques were
not statistically significant. A substantially longer period of
HCA, which averaged 54 minutes, was required for this tech-
nique as compared with the other 4 techniques.
Because of this and because of the lower stroke rate with
ascending aortic replacement (which was actually zero) and
an early mortality comparable with the other 2 commonly
used techniques, the authors recommend ascending aortic
replacement as the method of choice for managing patients
with severe atherosclerosis of the ascending aorta. 
Unfortunately, or perhaps fortunately, because of the low
prevalence of atherosclerotic disease in patients with aortic
valvular disease or coronary disease, no single center has
accumulated a large experience. In this series of almost 5000
cases of aortic valve surgery that Lytle and his colleagues
reviewed, only 62 cases of severe atherosclerosis of the
ascending aorta were identified. 
In our own experience with epiaortic scanning, which
began in 1987, we have identified only 84 patients over the
age of 50 with severe aortic atherosclerosis from a cohort of
4200 patients who were scanned. This represents approxi-
mately 2% of the group. In our series, all but 1 of the patients
underwent complete or partial ascending aortic replacement
with HCA. All underwent CABG and a substantial percent-
age required valve replacement or other procedures, includ-
ing carotid endarterectomy, an experience that is not dissimi-
lar from that described by Dr Lytle. The 30-day mortality was
8% and the stroke rate was 3.6%. 
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I agree with Dr Lytle that these patients are at increased risk
primarily because of the complexity of the procedures and the
presence of comorbid conditions. Atherosclerosis of the
ascending aorta has consistently been shown to be a marker
for diffuse atherosclerosis. 
So that the optimal strategy for management of such
patients can be determined, a multicenter study involving
large numbers of patients will be needed. I hope such a study
can be designed and implemented in the near future. 
I have 3 questions for Dr Lytle. If you are now using
epiaortic scanning routinely, has the frequency with which a
severely atherosclerotic aorta is detected increased or
decreased? It is conceivable that the number of cases detect-
ed might increase, but at the same time the number of patients
who required HCA might decrease because of the ability of
epiaortic scanning to identify areas where cannulas and
clamps can be safely placed on the ascending aorta. 
Do you manage patients undergoing AVR with severely
atherosclerotic aortas any differently from the way you man-
age patients undergoing CABG who also have severely
atherosclerotic aortas and in whom attachment of grafts to the
ascending aorta is necessary? 
How do you manage the patient with a calcified ascending
aorta who has severe aortic regurgitation during the period of
cooling that is required to establish HCA? 
Dr Lytle and his colleagues have addressed a very impor-
tant and persisting problem in cardiac surgery that is likely to
increase in frequency in the future, and they have identified a
strategy for management, given the present state of knowl-
edge, that I agree is the appropriate one. 
Dr Lytle. Thank you very much, Dr Kouchoukos. First of
all, I would remind the audience that all of these patients were
undergoing AVR. The reason that we chose patients undergo-
ing AVR to review is that we were forced to deal with the
aorta and CPB. For patients who have isolated coronary
artery disease, there are numerous strategies that can be used,
including off-pump surgery and bringing grafts off of patent
arterial grafts. Therefore, the options are many for patients
with isolated coronary artery disease. We have occasionally
used deep hypothermia, circulatory arrest, and AVR for
patients undergoing isolated coronary surgery, usually in the
face of this very soft atheromatous disease and in situations in
which the patients had extensive coronary artery disease and
needed numerous CABGs.
We do not routinely use epiaortic studies but almost rou-
tinely use transesophageal echocardiography. Transesoph-
ageal echocardiography does not always give us all the infor-
mation we need, but it alerts us to the problem of ascending
aortic atherosclerosis, and then we will do epiaortic echocar-
diography to look at the details of the distal ascending aorta
and aortic arch. When the aorta is atherosclerotic, we com-
monly will cannulate the axillary or innominate artery.
The management of a patient with a very bad aorta who
also has very severe aortic insufficiency is a major problem.
What we will usually do is try to get the patient as cold as we
can and use an atrioventricular vent to try to keep the left ven-
tricle from becoming distended. At times we end up having to
use circulatory arrest at a temperature that is not as low as I
described. We may be able to cool to 25°C, for example,
when the heart arrests and aortic insufficiency overwhelms
the vent and forces circulatory arrest. Fortunately, the replac-
ing the aorta at some point just proximal to the innominate
artery usually does not take much time. During HCA, we use
retrograde cerebral perfusion that is 14°C to 15°C, and with
a short period of arrest that appears to work out with reason-
able cerebral protection.
Dr Denton A. Cooley (Houston, Tex). A direct surgical
approach can be used for most patients with calcific disease
of the ascending aorta and arch. In some patients, however, an
indirect approach may be used with success and without the
complexity of HCA and the threat of cerebral complications.
We have recently devised a simple technique of apicoaortic
bypass through an anterolateral thoracotomy incision, enter-
ing the fifth intercostal space, for patients with severe and
complex disease of the left ventricular outflow. I will attempt
to describe what we have done. 
In the first step, a valve-containing conduit is attached to
the descending aorta and hemostasis is secured. We have used
a St Jude Medical valve. 
In the second step, CPB is begun with femoral venous and
arterial cannulation. The apex of the left ventricle is exposed
to allow attachment of a standard, rigid, right-angled fabric-
covered conduit with an attached sewing ring. We have used
the Medtronic left ventricular connector. Ventricular fibrilla-
tion is induced, the apex is cored, and the graft is attached
with sutures. 
In step 3, the 2 grafts are then anastomosed and ventricular
function is restored, usually by means of a countershock. 
Recently, we have used this simplified technique of api-
coaortic bypass in 7 patients who had a variety of left ven-
tricular outflow problems. The technique was used success-
fully to treat 2 patients with so-called porcelain aortas,
densely calcified sinuses of Valsalva, and severe aortic steno-
sis. In both patients exploration had been done by highly
competent surgeons in other institutions. The other 5 patients
also had complex cases of outflow tract obstruction and
numerous comorbidities, including previous mediastinal irra-
diation. All of the patients in the series had undergone previ-
ous cardiac surgery; most had undergone multiple conven-
tional procedures for congenital and acquired outflow
obstructions. 
Recently, this simplified technique of apicoaortic bypass
has also been adapted successfully for implantation of the
Jarvik 2000 continuous-flow left ventricular assist device
(CardioWest Technologies, Inc, Tucson, Ariz) without a con-
tained valved conduit. In the future, I believe the technique
will become standard for implantation of left ventricular
assist devices. 
Dr Lytle. Dr Cooley’s concept of a left ventricular–
descending aortic valved conduit is another interesting
innovation from someone who is one of my idols. I am sure
that this approach will be the right answer for some
patients. At The Cleveland Clinic, we did this type of pro-
cedure a couple of times back in the late 1970s but have not
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repeated it since that time. In those early days, it did not
seem to work out very well, probably because the technol-
ogy of the left ventricular connection was not as far
advanced as it is now. We now are in an era in which left
ventricular assists are used a lot, and the left ventricular
connection devices have improved. I do not doubt that a
valved conduit can help some patients.
Dr Lars G. Svensson (Burlington, Mass). Several years
ago we reported our experience doing endarterectomies for
calcified aortas, excluding atheromas, with similar findings,
namely, that patients who had had radiation, particularly CA
breast radiation, seemed to be prone to the development of
calcification. We have used techniques similar to yours, and
we have also used Dr Cooley’s technique. 
In 2 of our patients the axillary arteries could not be used
for CPB. They had had previous cardiac surgery and had aor-
tic valve stenosis. We inserted apical-descending conduits
without using CPB. On the basis of this experience, in a situ-
ation in which one is not able to use CPB, I think this tech-
nique is a good alternative. 
I have a couple of questions. You seem to be advocating
graft replacement now more than endarterectomy for aortic
repair. What do you do when the aortic arch contains a lot of
calcium and you are not able to drive your needle through the
calcium? Do you endarterectomize the descending aorta, and
what do you do with your end point in that situation? We have
always been concerned about creating aortic dissection,
although we have not seen it. However, the New York
University group had that happen as a complication in one of
their series of patients. 
Second, what do you do postoperatively after endarterecto-
my when a lot of raw medial tissue is exposed? Do you pre-
scribe clopidrogel (Plavix), aspirin, or heparin? We have pre-
scribed warfarin sodium (Coumadin) in many patients, even
though most of them have had biologic valves inserted. 
Dr Lytle. Realistically, in a lot of these patients we some-
times have to do a local endarterectomy to sew the graft in.
Where to end that endarterectomy is often a difficult question,
but with time and experience I think I have been more effective
in replacing the aorta and doing a localized endarterectomy than
endarterectomizing the entire aorta and then reclamping it. We
have not yet recognized a distal dissection caused by this tech-
nique, but we have worried about it. 
I do want to mention that we are reluctant to replace the
aorta with a Dacron graft in a patient who has had previous
mediastinal radiation. These patients are at increased risk for
wound complications and we would prefer not to have cloth
in the field.
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